Rex Bright

Rex Bright founded SkinMedica, Inc. in 2001, where he worked as President, Chief Executive Officer & Director from 2001 to 2012.
Mr. Bright also formerly worked at Seabright Associates, Inc., as President & Chief Executive Officer from 2015 to 2022, Global Leadership Network, as Chief Executive Officer from 2015 to 2022, Zerigo Health, Inc., as President, Chief Executive Officer & Director in 2018, VYNE Pharmaceuticals Ltd., as Independent Director from 2014 to 2020, Menlo Therapeutics, Inc., as Director, Skylit Corp., as Director, MDRejuvena, Inc., as Director, BIOCOM, as Director, Stratus Media Group, Inc., as Director in 2014, RestorGenex Corp., as Independent Director from 2014 to 2016, VYNE Pharmaceuticals, Inc., as Director, VYNE Therapeutics, Inc., as Independent Director from 2020 to 2022, Johnson & Johnson, as President-Ortho Dermatology, Allergan Pharmaceuticals Ltd., Inc., as President in 1987, Rotary International, Inc., as Member, North American Clinical Dermatologic Society, Inc., as Member, American Academy of Dermatology, as Member, Vistage International, Inc., as Member, Ortho Pharmaceutical Corp., as Principal in 1982, GlaxoSmithKline LLC, as Principal in 1985, China Biotechnology & Pharmaceutical Association, as Member, and International Society of Caricature Artists, as Member.
Mr. Bright received his undergraduate degree from Drury University.